SCHEMBL6660137

SCHEMBL6660137

O=[N+]([O-])c1cc[n+]([O-])c(N2CCC(CCOc3ccc4ncccc4c3)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
ALDH1A1 P00352 4/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 5/20 0.37
RAB9A P51151 4/20 0.37
KDM4E B2RXH2 2/20 0.37
TNF P01375 1/20 0.37
NOD1 Q9Y239 1/20 0.37
NR2F2 P24468 3/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
PDE10A Q9Y233 1/20 0.35
PPARG P37231 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GALR3 O60755 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663513 0.83 HTR1A (0.41) RAB9ASMN1; SMN2NPC1
SCHEMBL6660658 0.81 CHRNB4 (0.43) CYP2D6ALDH1A1LMNAMAPTKDM4E
SCHEMBL6658483 0.81 MAPT (0.45) ALDH1A1LMNAMAPTHTTMAPK1
SCHEMBL6659951 0.80 MAPT (0.40) CYP2D6MAPTRAB9ANPC1MAPK1
SCHEMBL6657970 0.80 ACHE (0.39) CYP2D6ALDH1A1LMNAMAPTRAB9A
SCHEMBL6658785 0.80 CHRNB4 (0.44) CHRNB4CHRNA3
SCHEMBL6657367 0.80 HTR6 (0.42) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6660649 0.80 KDM1A (0.39) ALDH1A1MAPTRAB9AHTTSMN1; SMN2
SCHEMBL6661589 0.79 LTA4H (0.41) ALDH1A1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL6657190 0.78 KCNH2 (0.42) MAPTPPARGPPARDPPARACHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004004715-A2 NOVEL DELTA OPIOID RECEPTOR LIGANDS GLAXOSMITHKLINE SPA (IT) 2004-01-15 WO disclosed